Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
Gufic BioSciences Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value(
)
509079
INE742B01025
57.2603242
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
GUFICBIO
57.24
4861.95
EPS(TTM)
Face Value(
)
Div & Yield %:
8.47
1
0.02
Particulars(INCOME)
Mar 2024
(
Cr)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Mar 2019
(
Cr)
Sales Turnover
806.67
690.62
779.16
487.70
378.84
350.77
Excise Duty
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
806.67
690.62
779.16
487.70
378.84
350.77
Other Income
2.18
2.57
3.10
3.73
5.79
4.17
Stock Adjustments
-0.57
33.39
19.39
-14.29
10.91
-13.77
Total Income
808.28
726.58
801.65
477.14
395.54
341.17
EXPENDITURE :
Raw Materials
389.32
365.21
431.35
236.00
190.45
167.00
Power & Fuel Cost
17.79
15.24
11.00
9.94
8.23
3.43
Employee Cost
109.63
86.73
85.61
66.22
58.59
46.85
Other Manufacturing Expenses
28.43
24.67
27.42
18.20
15.93
21.15
Selling & Administrative Expenses
104.31
87.63
77.97
45.93
54.08
46.29
Miscellaneous Expenses
10.75
9.88
17.16
13.20
10.35
6.29
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
660.22
589.36
650.51
389.49
337.63
291.01
Operating Profit
148.05
137.22
151.14
87.65
57.90
50.16
Interest
15.36
8.22
5.37
13.63
13.91
10.16
Gross Profit
132.69
129.00
145.77
74.02
43.99
40.00
Depreciation
17.02
22.28
18.93
16.31
13.86
4.65
Profit Before Tax
115.67
106.72
126.84
57.71
30.13
35.35
Tax
26.37
28.21
32.15
17.20
8.31
11.53
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
3.17
-1.19
-1.15
-3.72
-0.87
1.88
Reported Net Profit
86.14
79.70
95.84
44.23
22.69
21.94
Extraordinary Items
-1.67
0.02
0.05
0.02
0.01
0.03
Adjusted Net Profit
87.81
79.68
95.79
44.21
22.68
21.91
Adjustment below Net Profit
0.00
0.00
0.00
0.26
0.00
0.39
P & L Balance brought forward
267.29
188.55
93.68
49.58
27.36
44.11
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.97
0.97
0.97
0.39
0.47
0.47
P & L Balance carried down
352.46
267.29
188.55
93.68
49.58
65.98
Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
10.00
10.00
10.00
10.00
5.00
5.00
Dividend Per Share(Rs)
0.10
0.10
0.10
0.10
0.05
0.05
Earnings Per Share-Unit Curr
8.59
8.22
9.89
4.56
2.34
2.82
Earnings Per Share(Adj)-Unit Curr
8.59
8.22
9.89
4.56
2.34
2.82
Book Value-Unit Curr
53.11
35.88
27.76
17.89
13.34
9.68
Book Value(Adj)-Unit Curr
53.11
35.88
27.76
17.89
13.34
9.68